WGS Q3 2023 Earnings — GeneDx Holdings Corp. Revenue & Financial Results | Market Cap Arena

WGSGeneDx Holdings Corp.

$3B

Q3 2023 Earnings

Healthcare Medical - Healthcare Information Services

Income Statement

Revenue

$53M-36.0% YoY

Gross Profit

$25M47.4% margin

Operating Income

-$43M-80.6% margin

Net Income

-$42M-79.3% margin

EPS (Diluted)

$-1.64

QoQ Revenue Growth

+9.4%

Cash Flow

Operating Cash Flow

-$41M

Free Cash Flow

-$41M

Stock-Based Comp.

$430,000

Balance Sheet

Total Assets

$417M

Total Liabilities

$163M

Stockholders' Equity

$254M

Cash & Equivalents

$87M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$53M	$83M	-36.0%
Gross Profit	$25M	$14M	+86.4%
Operating Income	-$43M	-$91M	+52.7%
Net Income	-$42M	-$78M	+45.5%